Amrutanjan Health Care Ltd.

₹588.4

-2.8 (-0.5%)

AMRUTANJAN Share Price

Pharmaceuticals & Biotechnology

As on January 28, 2026

SectorHealthcare

IndustryPharmaceuticals & Biotechnology

Basic IndustryPharmaceuticals

Market Cap₹ 1,703 Cr

P/E Ratio83.59

Dividend Yield0.33 %

Trendline Performance

Unlock Stock of the Month

T&C*

Technicals

Indicators	Value	Signal
5-DMA	604.46	Bearish
10-DMA	607.01	Bearish
20-DMA	628.79	Bearish
50-DMA	659.42	Bearish
100-DMA	694.27	Bearish
200-DMA	696.73	Bearish

Historical Performance

1 Year

-13.1%

3 Years

-17.4%

5 Years

17.6%

10 Years

180.3%

Shareholding Pattern

Values Analysis

Loading chart...

Profit & Loss

Below figures are in Rs. Crores

Particulars	Mar-2016
Net Sales	1,867
Total Expenditure	1,560
Other Income	57
Operating Profit	365
Interest	4
Depreciation	33
Profit Before Tax	327
Consolidated Net Profit	206
Adjusted EPS	7

Compounded Sales Growth

10 Years:0

5 Years:0

3 Years:0

TTM:0

Compounded Profit Growth

10 Years:0

5 Years:0

3 Years:0

TTM:0

Stock Price CAGR

10 Years:10.6

5 Years:3.6

3 Years:-6.2

TTM:-12.7

Return on Equity

10 Years:1.8

5 Years:3.3

3 Years:4.3

last year:7

Quarterly Results

Below figures are in Rs. Crores

Particulars	Sep-2024	Dec-2024	Mar-2025	Jul-2025	Sep-2025
Sales	1,70,754	1,35,936	1,28,552	1,22,189	1,05,161
Expenses	63,042	56,557	52,457	45,459	34,856
Operating Profit	1,07,712	79,379	76,096	76,730	70,304
OPM %	63%	58%	59%	63%	67%
Other Income	33,912	31,759	27,333	24,879	18,947
Interest	77,780	58,584	59,248	62,137	53,713
Depreciation	2,345	1,681	1,385	1,277	1,221
Profit Before Tax	61,498	50,873	42,796	38,195	34,318
Tax %	25%	25%	26%	29%	35%
Net Profit	46,149	38,151	31,857	27,296	22,446
EPS in Rs	83	69	58	50	42

Balance Sheet

Below figures are in Rs. Crores

Particulars	Mar-2016
Share Capital	29
Total Reserves	1,058
Long-Term Borrowings	---
Total Non-Current Liabilities	37
Other Current Liabilities	144
Short Term Borrowings	25
Total Liabilities	1,404
Capital Work in Progress	7
Long Term Loans & Advances	13
Currents Investments	---
Short Term Loans and Advances	121
Total Current Assets	1,005
Total Assets	1,404
Adjusted Book Value	37

Positive

(80 to 100)

Neutral

(60 to 79)

Negative

(0 to 59)

The stock has a high PE of 83.59, indicating expensive valuation or elevated growth expectations.
Over the last three years, the stock delivered a weak 3-year price CAGR of -6.3%, indicating poor shareholder returns.
The stock carries a beta of 0.8, indicating volatility broadly in line with the market.
In the last financial year, the company reported an EBITDA of ₹365 million, reflecting positive operating performance.
In the previous financial year, the company generated revenue of ₹1867 million, suggesting a mid-sized operation.

Investment Calculator

Investment Amount:

₹

Investment Amount: ₹ 1000000

Current Value: ₹ 873061.8

No. of Shares: 1484 (Approx)

Performance:-12.7%

P/L: ₹-126938.2

NIFTY Performance: 9.4%

1 day Top Gainers